LOX-1 the multifunctional receptor underlying cardiovascular dysfunction

S Ogura, A Kakino, Y Sato, Y Fujita, S Iwamoto… - Circulation …, 2009 - jstage.jst.go.jp
Oxidatively modified low-density lipoprotein (oxLDL) is implicated in the pathogenesis of
atherosclerosis. Endothelial dysfunction is the initial change in the vascular wall that induces …

LOX-1 The Multifunctional Receptor Underlying Cardiovascular Dysfunction

S Ogura, A Kakino, Y Sato, Y Fujita, S Iwamoto… - Circulation …, 2009 - jlc.jst.go.jp
Oxidatively modified low-density lipoprotein (oxLDL) is implicated in the pathogenesis of
atherosclerosis. Endothelial dysfunction is the initial change in the vascular wall that induces …

[PDF][PDF] LOX-1

Circulation Journal, 2009 - researchgate.net
Oxidatively modified low-density lipoprotein (oxLDL) is implicated in the pathogenesis of
atherosclerosis. Endothelial dysfunction is the initial change in the vascular wall that induces …

Lox-1: the multifunctional receptor underlying cardiovascular dysfunction.

S Ogura, A Kakino, Y Sato, Y Fujita… - … : Official Journal of the …, 2009 - europepmc.org
Oxidatively modified low-density lipoprotein (oxLDL) is implicated in the pathogenesis of
atherosclerosis. Endothelial dysfunction is the initial change in the vascular wall that induces …

LOX-1 The Multifunctional Receptor Underlying Cardiovascular Dysfunction

S Ogura, A Kakino, Y Sato, Y Fujita, S Iwamoto… - Circulation …, 2009 - jstage.jst.go.jp
Oxidatively modified low-density lipoprotein (oxLDL) is implicated in the pathogenesis of
atherosclerosis. Endothelial dysfunction is the initial change in the vascular wall that induces …

Lox-1: the multifunctional receptor underlying cardiovascular dysfunction

S Ogura, A Kakino, Y Sato, Y Fujita… - … : official journal of …, 2009 - pubmed.ncbi.nlm.nih.gov
Oxidatively modified low-density lipoprotein (oxLDL) is implicated in the pathogenesis of
atherosclerosis. Endothelial dysfunction is the initial change in the vascular wall that induces …

LOX-1 The Multifunctional Receptor Underlying Cardiovascular Dysfunction

O Sayoko, K Akemi, S Yuko, F Yoshiko, I Shin… - 日本循環器學誌, 2009 - cir.nii.ac.jp
抄録 Oxidatively modified low-density lipoprotein (oxLDL) is implicated in the pathogenesis
of atherosclerosis. Endothelial dysfunction is the initial change in the vascular wall that …

[引用][C] LOX-1 The Multifunctional Receptor Underlying Cardiovascular Dysfunction

S OGURA, A KAKINO, Y SATO, Y FUJITA… - Circulation …, 2009 - jglobal.jst.go.jp
4. Aoyama T, Sawamura T, Furutani Y, Matsuoka R, Yoshida MC, Fujiwara H, et al. Structure
and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein …

[PDF][PDF] LOX-1

Circulation Journal, 2009 - scholar.archive.org
Oxidatively modified low-density lipoprotein (oxLDL) is implicated in the pathogenesis of
atherosclerosis. Endothelial dysfunction is the initial change in the vascular wall that induces …

LOX-1 The Multifunctional Receptor Underlying Cardiovascular Dysfunction

S Ogura, A Kakino, Y Sato, Y Fujita, S Iwamoto… - Circulation …, 2009 - jlc.jst.go.jp
Oxidatively modified low-density lipoprotein (oxLDL) is implicated in the pathogenesis of
atherosclerosis. Endothelial dysfunction is the initial change in the vascular wall that induces …